These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 27698552)

  • 1. Profile of adalimumab and its potential in the treatment of uveitis.
    Balevic SJ; Rabinovich CE
    Drug Des Devel Ther; 2016; 10():2997-3003. PubMed ID: 27698552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of adalimumab treatment for non-infectious uveitis.
    Hasegawa E; Takeda A; Yawata N; Sonoda KH
    Immunol Med; 2019 Jun; 42(2):79-83. PubMed ID: 31315546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series.
    La Torre F; Cattalini M; Teruzzi B; Meini A; Moramarco F; Iannone F
    BMC Res Notes; 2014 May; 7():316. PubMed ID: 24886032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis.
    Semeraro F; Arcidiacono B; Nascimbeni G; Angi M; Parolini B; Costagliola C
    Drug Des Devel Ther; 2014; 8():341-8. PubMed ID: 24711694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital].
    Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B
    J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).
    Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW;
    Trials; 2014 Jan; 15():14. PubMed ID: 24405833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab for the treatment of uveitis.
    LaMattina KC; Goldstein DA
    Expert Rev Clin Immunol; 2017 Mar; 13(3):181-188. PubMed ID: 28140700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
    Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
    Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile idiopathic arthritis-associated uveitis.
    Sen ES; Ramanan AV
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):517-534. PubMed ID: 29773271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
    Ramanan AV; Dick AD; Jones AP; McKay A; Williamson PR; Compeyrot-Lacassagne S; Hardwick B; Hickey H; Hughes D; Woo P; Benton D; Edelsten C; Beresford MW;
    N Engl J Med; 2017 Apr; 376(17):1637-1646. PubMed ID: 28445659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research update of anti-TNF-α biologic agents in the treatment of uveitis].
    Fan F; Zhou M; Luo Y
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):285-8. PubMed ID: 23866712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
    Deitch I; Amer R; Tomkins-Netzer O; Habot-Wilner Z; Friling R; Neumann R; Kramer M
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab for the treatment of refractory noninfectious paediatric uveitis.
    Muñoz-Gallego A; Barral E; Enríquez E; Tejada P; Barceló A; de Inocencio J
    Int Ophthalmol; 2017 Jun; 37(3):719-725. PubMed ID: 27432171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uveitis in Children and Adolescents.
    Chang MH; Shantha JG; Fondriest JJ; Lo MS; Angeles-Han ST
    Rheum Dis Clin North Am; 2021 Nov; 47(4):619-641. PubMed ID: 34635295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis.
    Erckens RJ; Mostard RL; Wijnen PA; Schouten JS; Drent M
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):713-20. PubMed ID: 22119879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis.
    García-De-Vicuña C; Díaz-Llopis M; Salom D; Bou R; Díaz-Cascajosa J; Cordero-Coma M; Ortega G; Ortego-Centeno N; Suarez-De-Figueroa M; Cruz-Martínez J; Fonollosa A; Blanco R; García-Aparicio ÁM; Benítez-Del-Castillo JM; Antón J
    Mediators Inflamm; 2013; 2013():560632. PubMed ID: 24489444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.
    Leinonen ST; Aalto K; Kotaniemi KM; Kivelä TT
    Clin Exp Rheumatol; 2017; 35(6):1043-1046. PubMed ID: 29148422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of neurosarcoidosis secondary to treatment of etanercept and review of the literature.
    Berrios I; Jun-O'Connell A; Ghiran S; Ionete C
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26150616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
    Foeldvari I; Nielsen S; Kümmerle-Deschner J; Espada G; Horneff G; Bica B; Olivieri AN; Wierk A; Saurenmann RK
    J Rheumatol; 2007 May; 34(5):1146-50. PubMed ID: 17343318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults.
    Borrás-Blasco J; Casterá DE; Cortes X; Abad FJ; Rosique-Robles JD; Mallench LG
    Int J Clin Pharmacol Ther; 2015 May; 53(5):377-90. PubMed ID: 25345430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.